Adimolol
| |||
| Klinički podaci | |||
|---|---|---|---|
| Identifikatori | |||
| CAS broj | 78459-19-5 | ||
| ATC kod | nije dodeljen | ||
| PubChem[1][2] | 71227 | ||
| ChemSpider[3] | 64362 | ||
| UNII | B6CJY5K2ST 
| ||
| Hemijski podaci | |||
| Formula | C25H29N3O3 | ||
| Mol. masa | 419,52 g/mol | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | |||
Adimolol (MEN-935) je antihipertenzivni agens koji deluje kao neselektivni antagonist α1-, α2-, i β-adrenergičkog receptora .[4]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Palluk R, Hoefke W, Gaida W, Mierau J, Bechtel WD (July 1986). „Interactions of MEN 935 (adimolol), a long acting beta- and alpha-adrenolytic antihypertensive agent, with postsynaptic alpha-adrenoceptors in different isolated blood vessels--influence of angiotensin II”. Naunyn-Schmiedeberg's Archives of Pharmacology 333 (3): 277–83. PMID 3020439.